GeneDx Holdings Corp (NAS:WGS)
$ 22.39 -1.63 (-6.79%) Market Cap: 585.52 Mil Enterprise Value: 633.60 Mil PE Ratio: 0 PB Ratio: 3.03 GF Score: 28/100

Sema4 Holdings Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 01:30PM GMT
Release Date Price: $289.08 (-0.68%)
Tejas Savant
Morgan Stanley - Analyst

Hey, everyone. Good morning. Thanks for joining us today on the third day of our healthcare conference here. I am Tejas Savant, and I cover the life science tools and diagnostic sector at Morgan Stanley. Delighted to have Sema4 join us this morning. And representing the Company, we have Eric Schadt, CEO, and Isaac Ro, CFO. So welcome, gents.

Before we get into the Q&A, just some important disclosures. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep. So Eric, before we get into the weeds on the story, can you just please give us an overview of the genesis of Sema4 and its evolution for those on the webcast not as familiar with the business model.

Eric Schadt
Sema4 - Founder & CEO

Sure, Tejas, and thanks for having us today. So Sema4 is a health intelligence company born and raised in the Mount Sinai Health System in New York. We spun out about four and a half years ago and the charter at Mount

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot